Cargando…
Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT) are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with mold-active azoles has been challenged recently because of drug–drug interactions with novel targeted therapies. T...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397156/ https://www.ncbi.nlm.nih.gov/pubmed/34436127 http://dx.doi.org/10.3390/jof7080588 |
_version_ | 1783744551493566464 |
---|---|
author | Bergamasco, Maria Daniela Pereira, Carlos Alberto P. Arrais-Rodrigues, Celso Ferreira, Diogo B. Baiocchi, Otavio Kerbauy, Fabio Nucci, Marcio Colombo, Arnaldo Lopes |
author_facet | Bergamasco, Maria Daniela Pereira, Carlos Alberto P. Arrais-Rodrigues, Celso Ferreira, Diogo B. Baiocchi, Otavio Kerbauy, Fabio Nucci, Marcio Colombo, Arnaldo Lopes |
author_sort | Bergamasco, Maria Daniela |
collection | PubMed |
description | Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT) are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with mold-active azoles has been challenged recently because of drug–drug interactions with novel targeted therapies. This is a retrospective, single-center cohort study of consecutive cases of proven or probable IFD, diagnosed between 2009 and 2019, in adult hematologic patients and HCT recipients managed with fluconazole prophylaxis and an antifungal diagnostic-driven approach for mold infection. During the study period, 94 cases of IFD occurred among 664 hematologic patients and 316 HCT recipients. The frequency among patients with allogeneic HCT, autologous HCT, acute leukemia and other hematologic malignancies was 8.9%, 1.6%, 17.3%, and 6.4%, respectively. Aspergillosis was the leading IFD (53.2%), followed by fusariosis (18.1%), candidiasis (10.6%), and cryptococcosis (8.5%). The overall 6-week mortality rate was 37.2%, and varied according to the host and the etiology of IFD, from 28% in aspergillosis to 52.9% in fusariosis. Although IFD occurred frequently in our cohort of patients managed with an antifungal diagnostic driven approach, mortality rates were comparable to other studies. In the face of challenges posed by the use of anti-mold prophylaxis, this strategy remains a reasonable alternative. |
format | Online Article Text |
id | pubmed-8397156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83971562021-08-28 Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach Bergamasco, Maria Daniela Pereira, Carlos Alberto P. Arrais-Rodrigues, Celso Ferreira, Diogo B. Baiocchi, Otavio Kerbauy, Fabio Nucci, Marcio Colombo, Arnaldo Lopes J Fungi (Basel) Article Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT) are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with mold-active azoles has been challenged recently because of drug–drug interactions with novel targeted therapies. This is a retrospective, single-center cohort study of consecutive cases of proven or probable IFD, diagnosed between 2009 and 2019, in adult hematologic patients and HCT recipients managed with fluconazole prophylaxis and an antifungal diagnostic-driven approach for mold infection. During the study period, 94 cases of IFD occurred among 664 hematologic patients and 316 HCT recipients. The frequency among patients with allogeneic HCT, autologous HCT, acute leukemia and other hematologic malignancies was 8.9%, 1.6%, 17.3%, and 6.4%, respectively. Aspergillosis was the leading IFD (53.2%), followed by fusariosis (18.1%), candidiasis (10.6%), and cryptococcosis (8.5%). The overall 6-week mortality rate was 37.2%, and varied according to the host and the etiology of IFD, from 28% in aspergillosis to 52.9% in fusariosis. Although IFD occurred frequently in our cohort of patients managed with an antifungal diagnostic driven approach, mortality rates were comparable to other studies. In the face of challenges posed by the use of anti-mold prophylaxis, this strategy remains a reasonable alternative. MDPI 2021-07-23 /pmc/articles/PMC8397156/ /pubmed/34436127 http://dx.doi.org/10.3390/jof7080588 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bergamasco, Maria Daniela Pereira, Carlos Alberto P. Arrais-Rodrigues, Celso Ferreira, Diogo B. Baiocchi, Otavio Kerbauy, Fabio Nucci, Marcio Colombo, Arnaldo Lopes Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach |
title | Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach |
title_full | Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach |
title_fullStr | Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach |
title_full_unstemmed | Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach |
title_short | Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach |
title_sort | epidemiology of invasive fungal diseases in patients with hematologic malignancies and hematopoietic cell transplantation recipients managed with an antifungal diagnostic driven approach |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397156/ https://www.ncbi.nlm.nih.gov/pubmed/34436127 http://dx.doi.org/10.3390/jof7080588 |
work_keys_str_mv | AT bergamascomariadaniela epidemiologyofinvasivefungaldiseasesinpatientswithhematologicmalignanciesandhematopoieticcelltransplantationrecipientsmanagedwithanantifungaldiagnosticdrivenapproach AT pereiracarlosalbertop epidemiologyofinvasivefungaldiseasesinpatientswithhematologicmalignanciesandhematopoieticcelltransplantationrecipientsmanagedwithanantifungaldiagnosticdrivenapproach AT arraisrodriguescelso epidemiologyofinvasivefungaldiseasesinpatientswithhematologicmalignanciesandhematopoieticcelltransplantationrecipientsmanagedwithanantifungaldiagnosticdrivenapproach AT ferreiradiogob epidemiologyofinvasivefungaldiseasesinpatientswithhematologicmalignanciesandhematopoieticcelltransplantationrecipientsmanagedwithanantifungaldiagnosticdrivenapproach AT baiocchiotavio epidemiologyofinvasivefungaldiseasesinpatientswithhematologicmalignanciesandhematopoieticcelltransplantationrecipientsmanagedwithanantifungaldiagnosticdrivenapproach AT kerbauyfabio epidemiologyofinvasivefungaldiseasesinpatientswithhematologicmalignanciesandhematopoieticcelltransplantationrecipientsmanagedwithanantifungaldiagnosticdrivenapproach AT nuccimarcio epidemiologyofinvasivefungaldiseasesinpatientswithhematologicmalignanciesandhematopoieticcelltransplantationrecipientsmanagedwithanantifungaldiagnosticdrivenapproach AT colomboarnaldolopes epidemiologyofinvasivefungaldiseasesinpatientswithhematologicmalignanciesandhematopoieticcelltransplantationrecipientsmanagedwithanantifungaldiagnosticdrivenapproach |